10-41,
What's the relavance to RVX here? Are you comparing Biogen's aducanumab to the potential of apabetalone for neurodegenerative disease? What trial update are you referring to? Please do us all a favor and provide some more context to your posts (like this one, as well as the Hepalink one) so as not to leave us guessing what the ? you are talking about.
BDAZ